Huadong Medicine Co (SZSE:000963) Total Stockholders Equity : ¥21,048 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Total Stockholders Equity?

Huadong Medicine Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ¥21,048 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Huadong Medicine Co's Book Value per Share for the quarter that ended in Dec. 2023 was ¥12.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Huadong Medicine Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.08.

Huadong Medicine Co Total Stockholders Equity Historical Data

The historical data trend for Huadong Medicine Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Total Stockholders Equity Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

12,309.48

14,619.82

16,579.37

18,577.92

21,047.61

Huadong Medicine Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															18,577.92	19,314.07	19,532.40	20,298.21	21,047.61

Huadong Medicine Co (SZSE:000963) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Huadong Medicine Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(21047.61	-	0)	/	1754.43
	=	12.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Huadong Medicine Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1181.723	+	577.455)	/	21047.61
	=	0.08

Huadong Medicine Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines